Abstract
We report 4 patients who developed hyperphosphatemia while receiving liposomal amphotericin B to treat an invasive fungal infection. Resolution of the hyperphosphatemia occurred after transition to amphotericin B lipid complex. This phenomenon may occur more commonly in patients with mild to moderate renal insufficiency.
Original language | English (US) |
---|---|
Pages (from-to) | 77-79 |
Number of pages | 3 |
Journal | Pediatric Infectious Disease Journal |
Volume | 27 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2008 |
Externally published | Yes |
Keywords
- Amphotericin B
- Antifungal
- Hyperphosphatemia
- Invasive fungal infection
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Microbiology (medical)